Asa Wesenberg

An intravaginal ring that releases three antiviral agents and a contraceptive blocks SHIV-RT infection, reduces HSV-2 shedding, and suppresses hormonal cycling in rhesus macaques

A. Gettie, J. Blanchard, J. Lifson, 2017, Drug Delivery and Translational Research.

Results of a phase 1, randomized, placebo-controlled first-in-human trial of griffithsin formulated in a carrageenan vaginal gel

B. Friedland, Yupu Liang, R. Fichorova, 2022, PloS one.

Griffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivo

W. Heneine, M. Peet, M. Lal, 2018, Nature Communications.

A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy.

A. Gettie, J. Blanchard, Narender Kumar, 2015, Journal of controlled release : official journal of the Controlled Release Society.

Development of a Vaginal Fast-Dissolving Insert Combining Griffithsin and Carrageenan for Potential Use Against Sexually Transmitted Infections.

M. Lal, O. Mizenina, Shweta R. Ugaonkar, 2018, Journal of pharmaceutical sciences.